SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-16-010413
Filing Date
2016-01-28
Accepted
2016-01-28 06:01:04
Documents
3
Period of Report
2016-01-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k012716_oxysuretherap.htm 8-K 19288
2 LETTER DATED JANUARY 26, 2016. f8k012716ex99i_oxysuretherap.htm EX-99.1 45631
3 GRAPHIC ex99i_001.jpg GRAPHIC 22067
  Complete submission text file 0001213900-16-010413.txt   96663
Mailing Address 10880 JOHN W. ELLIOTT ROAD SUITE 600 Frisco TX 75034
Business Address 10880 JOHN W. ELLIOTT ROAD SUITE 600 Frisco TX 75034 (972) 294-6450
OxySure Therapeutics, Inc. (Filer) CIK: 0001413797 (see all company filings)

IRS No.: 710960725 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54137 | Film No.: 161366485
SIC: 3841 Surgical & Medical Instruments & Apparatus